Atrial Fibrillation and Aortic Ectasia as Complications of Primary Aldosteronism: Focus on Pathophysiological Aspects
暂无分享,去创建一个
M. Parasiliti-Caprino | E. Ghigo | M. Maccario | F. Ponzetto | F. Bioletto | M. Bollati | Chiara Lopez
[1] J. Finnie,et al. Histological regional analysis of the aortic root and thoracic ascending aorta: a complete analysis of aneurysms from root to arch , 2021, Journal of Cardiothoracic Surgery.
[2] G. Wells,et al. Aortic Stiffness, Central Blood Pressure, and Pulsatile Arterial Load Predict Future Thoracic Aortic Aneurysm Expansion , 2020, Hypertension.
[3] C. Hung,et al. Left ventricular remodeling and dysfunction in primary aldosteronism , 2020, Journal of Human Hypertension.
[4] Jeroen J. Bax,et al. 2020 ESC Guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association of Cardio-Thoracic Surgery (EACTS). , 2020, European heart journal.
[5] F. Luo,et al. Is primary aldosteronism a potential risk factor for aortic dissection? A case report and literature review , 2020, BMC Endocrine Disorders.
[6] P. Hopkins,et al. The Unrecognized Prevalence of Primary Aldosteronism , 2020, Annals of Internal Medicine.
[7] M. Parasiliti-Caprino,et al. Prevalence of primary aldosteronism and association with cardiovascular complications in patients with resistant and refractory hypertension. , 2020, Journal of hypertension.
[8] G. Parati,et al. The 2020 Italian Society of Arterial Hypertension (SIIA) practical guidelines for the management of primary aldosteronism , 2020, International Journal of Cardiology. Hypertension.
[9] M. Muiesan,et al. Atrial fibrillation as presenting sign of primary aldosteronism: results of the Prospective Appraisal on the Prevalence of Primary Aldosteronism in Hypertensive (PAPPHY) study. , 2019, Journal of hypertension.
[10] F. Beygui,et al. Effects of Mineralocorticoid Receptor Antagonists on Atrial Fibrillation Occurrence: A Systematic Review, Meta‐Analysis, and Meta‐Regression to Identify Modifying Factors , 2019, Journal of the American Heart Association.
[11] L. Sechi,et al. Renal damage in primary aldosteronism: a systematic review and meta-analysis. , 2019, Journal of hypertension.
[12] P. M. van de Ven,et al. Hypertension with primary aldosteronism is associated with increased carotid intima‐media thickness and endothelial dysfunction , 2019, Journal of clinical hypertension.
[13] G. Di Dalmazi,et al. Larger ascending aorta in primary aldosteronism: a 3-year prospective evaluation of adrenalectomy vs. medical treatment , 2018, Endocrine.
[14] G. Curhan,et al. Renal Outcomes in Medically and Surgically Treated Primary Aldosteronism , 2018, Hypertension.
[15] Youbin Deng,et al. Enlarged Size and Impaired Elastic Properties of the Ascending Aorta are Associated with Endothelial Dysfunction and Elevated Plasma Matrix Metalloproteinase-2 Level in Patients with Bicuspid Aortic Valve. , 2018, Ultrasound in medicine & biology.
[16] C. Zoccali,et al. Adrenalectomy Lowers Incident Atrial Fibrillation in Primary Aldosteronism Patients at Long Term , 2018, Hypertension.
[17] M. Lombès,et al. Specific Activation of the Alternative Cardiac Promoter of Cacna1c by the Mineralocorticoid Receptor , 2018, Circulation research.
[18] A. Rosengren,et al. Primary aldosteronism and thyroid disorders in atrial fibrillation: A Swedish nationwide case–control study , 2018, European Journal of Preventive Cardiology.
[19] Hong-zhao Li,et al. Mineralocorticoid receptor antagonism protects the aorta from vascular smooth muscle cell proliferation and collagen deposition in a rat model of adrenal aldosterone-producing adenoma , 2017, Journal of Physiology and Biochemistry.
[20] G. Johannsson,et al. Aldosterone to Renin Ratio as a Screening Instrument for Primary Aldosteronism in a Middle-Aged Population with Atrial Fibrillation , 2017, Hormone and Metabolic Research.
[21] W. Young,et al. Outcomes after adrenalectomy for unilateral primary aldosteronism: an international consensus on outcome measures and analysis of remission rates in an international cohort. , 2017, The lancet. Diabetes & endocrinology.
[22] R. Touyz,et al. Vascular dysfunction and fibrosis in stroke-prone spontaneously hypertensive rats: The aldosterone-mineralocorticoid receptor-Nox1 axis , 2017, Life sciences.
[23] Emelia J. Benjamin,et al. Atrial Fibrillation: Epidemiology, Pathophysiology, and Clinical Outcomes , 2017, Circulation research.
[24] F. Veglio,et al. Prevalence and Clinical Manifestations of Primary Aldosteronism Encountered in Primary Care Practice. , 2017, Journal of the American College of Cardiology.
[25] P. Sanders,et al. Aldosterone Pathway Blockade to Prevent Atrial Fibrillation: A Systematic Review and Meta-Analysis. , 2017, International journal of cardiology.
[26] Zhilin Qu,et al. Electrophysiology of Hypokalemia and Hyperkalemia. , 2017, Circulation. Arrhythmia and electrophysiology.
[27] Yen-Hung Lin,et al. Long term outcome of Aldosteronism after target treatments , 2016, Scientific Reports.
[28] Tong Liu,et al. Mineralocorticoid receptor antagonists and atrial fibrillation: a meta-analysis. , 2016, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.
[29] W. Young,et al. The Management of Primary Aldosteronism: Case Detection, Diagnosis, and Treatment: An Endocrine Society Clinical Practice Guideline. , 2016, The Journal of clinical endocrinology and metabolism.
[30] M. Novello,et al. Aldosterone and Left Ventricular Remodeling , 2015, Hormone and Metabolic Research.
[31] M. Metra,et al. The effect of aldosterone-antagonist therapy on aortic elastic properties in patients with nonischemic dilated cardiomyopathy , 2015, Journal of cardiovascular medicine.
[32] A. Nakashima,et al. Effect of Aldosterone-Producing Adenoma on Endothelial Function and Rho-Associated Kinase Activity in Patients With Primary Aldosteronism , 2015, Hypertension.
[33] I. Komuro,et al. Impairment of flow-mediated dilation correlates with aortic dilation in patients with Marfan syndrome , 2014, Heart and Vessels.
[34] Shun-Fa Yang,et al. Cross-talk between mineralocorticoid receptor/angiotensin II type 1 receptor and mitogen-activated protein kinase pathways underlies aldosterone-induced atrial fibrotic responses in HL-1 cardiomyocytes. , 2013, International journal of cardiology.
[35] D. V. Van Wagoner,et al. Impact of aldosterone antagonists on the substrate for atrial fibrillation: aldosterone promotes oxidative stress and atrial structural/electrical remodeling. , 2013, International journal of cardiology.
[36] R. Weiss,et al. Oxidized Ca2+/Calmodulin-Dependent Protein Kinase II Triggers Atrial Fibrillation , 2013, Circulation.
[37] U. Laufs,et al. The Mineralocorticoid Receptor Promotes Fibrotic Remodeling in Atrial Fibrillation* , 2014, The Journal of Biological Chemistry.
[38] A. Pessina,et al. Long-Term Control of Arterial Hypertension and Regression of Left Ventricular Hypertrophy With Treatment of Primary Aldosteronism , 2013, Hypertension.
[39] Shu Liu,et al. Mineralocorticoid Receptor Agonists Induce Mouse Aortic Aneurysm Formation and Rupture in the Presence of High Salt , 2013, Arteriosclerosis, thrombosis, and vascular biology.
[40] N. Brown. Contribution of aldosterone to cardiovascular and renal inflammation and fibrosis , 2013, Nature Reviews Nephrology.
[41] C. Delcayre,et al. Aldosterone Mediates Cardiac Fibrosis in the Setting of Hypertension , 2013, Current Hypertension Reports.
[42] E. Schiffrin,et al. Vascular Actions of Aldosterone , 2012, Journal of Vascular Research.
[43] M. Allessie,et al. Aldosterone promotes atrial fibrillation. , 2012, European heart journal.
[44] U. Hoppe,et al. Spironolactone Prevents Aldosterone Induced Increased Duration of Atrial Fibrillation in Rat , 2012, Cellular Physiology and Biochemistry.
[45] S. Mildenberger,et al. Influence of Aldosterone and Salt or Ouabain in A10 Rat Aorta Smooth Muscle Cells , 2012, Journal of Vascular Research.
[46] Mark E. Anderson,et al. Oxidation of CaMKII determines the cardiotoxic effects of aldosterone , 2011, Nature Medicine.
[47] J. Schreieck,et al. Effects of selective mineralocorticoid receptor antagonism on atrial ion currents and early ionic tachycardia-induced electrical remodelling in rabbits , 2010, Naunyn-Schmiedeberg's Archives of Pharmacology.
[48] Y. Li,et al. Effects of spironolactone on atrial structural remodelling in a canine model of atrial fibrillation produced by prolonged atrial pacing , 2010, British journal of pharmacology.
[49] M. Iida,et al. Role of Rho kinase and oxidative stress in cardiac fibrosis induced by aldosterone and salt in angiotensin type 1a receptor knockout mice , 2010, Regulatory Peptides.
[50] K. Kuo,et al. Increased expression of mineralocorticoid receptor in human atrial fibrillation and a cellular model of atrial fibrillation. , 2010, Journal of the American College of Cardiology.
[51] J. Floras,et al. Endothelial function, carotid-femoral stiffness, and plasma matrix metalloproteinase-2 in men with bicuspid aortic valve and dilated aorta. , 2010, Journal of the American College of Cardiology.
[52] B. Wożakowska-Kapłon,et al. A Decrease in Serum Aldosterone Level is Associated with Maintenance of Sinus Rhythm after Successful Cardioversion of Atrial Fibrillation , 2010, Pacing and clinical electrophysiology : PACE.
[53] G. Lip,et al. Atrial fibrillation in primary aldosteronism , 2009, Journal of the renin-angiotensin-aldosterone system : JRAAS.
[54] K. Weber,et al. Coupled Calcium and Zinc Dyshomeostasis and Oxidative Stress in Cardiac Myocytes and Mitochondria of Rats With Chronic Aldosteronism , 2009, Journal of cardiovascular pharmacology.
[55] F. Jaisser,et al. Mineralocorticoid Modulation of Cardiac Ryanodine Receptor Activity Is Associated With Downregulation of FK506-Binding Proteins , 2009, Circulation.
[56] G. Fishman,et al. Gap Junction Remodeling and Spironolactone-Dependent Reverse Remodeling in the Hypertrophied Heart , 2009, Circulation research.
[57] J. Sowers,et al. Mineralocorticoid Receptor Antagonism Attenuates Vascular Apoptosis and Injury via Rescuing Protein Kinase B Activation , 2009, Hypertension.
[58] L. Ghiadoni,et al. Arterial stiffness, intima-media thickness and carotid artery fibrosis in patients with primary aldosteronism , 2008, Journal of hypertension.
[59] S. Nattel,et al. Atrial fibrosis: mechanisms and clinical relevance in atrial fibrillation. , 2008, Journal of the American College of Cardiology.
[60] L. Sechi,et al. Cardiovascular outcomes in patients with primary aldosteronism after treatment. , 2008, Archives of internal medicine.
[61] W. Han,et al. Effects of spironolactone on electrical and structural remodeling of atrium in congestive heart failure dogs. , 2008, Chinese medical journal.
[62] J. Egido,et al. Interactions between aldosterone and connective tissue growth factor in vascular and renal damage in spontaneously hypertensive rats , 2007, Journal of hypertension.
[63] S. Mildenberger,et al. Altered collagen homeostasis in human aortic smooth muscle cells (HAoSMCs) induced by aldosterone , 2007, Pflügers Archiv - European Journal of Physiology.
[64] T. Zelinka,et al. Increased arterial wall stiffness in primary aldosteronism in comparison with essential hypertension. , 2006, American journal of hypertension.
[65] A. Shah,et al. Aldosterone mediates angiotensin II‐induced interstitial cardiac fibrosis via a Nox2‐containing NADPH oxidase , 2006, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[66] C. Massey,et al. Is Primary Hyperaldosteronism a Risk Factor for Aortic Dissection? , 2006, Cardiology.
[67] F. Jaisser,et al. A direct relationship between plasma aldosterone and cardiac L‐type Ca2+ current in mice , 2005, The Journal of physiology.
[68] E. Vicaut,et al. Spironolactone reduces fibrosis of dilated atria during heart failure in rats with myocardial infarction. , 2005, European heart journal.
[69] S. Barrère‐lemaire,et al. Aldosterone increases T-type calcium channel expression and in vitro beating frequency in neonatal rat cardiomyocytes. , 2005, Cardiovascular research.
[70] G. Fishman,et al. Data Supplement (unedited) at: , 2005 .
[71] P. Milliez,et al. Evidence for an increased rate of cardiovascular events in patients with primary aldosteronism. , 2005, Journal of the American College of Cardiology.
[72] R. Liao,et al. Mineralocorticoid Receptor Inhibition Ameliorates the Transition to Myocardial Failure and Decreases Oxidative Stress and Inflammation in Mice With Chronic Pressure Overload , 2005, Circulation.
[73] D. Calhoun,et al. Impaired Endothelium-Dependent Flow-Mediated Vasodilation in Hypertensive Subjects With Hyperaldosteronism , 2004, Circulation.
[74] J. Blacher,et al. [Primary aldosteronism. A risk factor for aortic dissection?]. , 2003, Journal des maladies vasculaires.
[75] J. Delyani,et al. Selective aldosterone blockade prevents angiotensin II/salt-induced vascular inflammation in the rat heart. , 2002, Endocrinology.
[76] M. Safar,et al. Increased Carotid Wall Elastic Modulus and Fibronectin in Aldosterone-Salt–Treated Rats: Effects of Eplerenone , 2002, Circulation.
[77] K. Weber,et al. Aldosterone-induced inflammation in the rat heart : role of oxidative stress. , 2002, The American journal of pathology.
[78] E. Schiffrin,et al. Cardiac and vascular fibrosis and hypertrophy in aldosterone-infused rats: role of endothelin-1. , 2002, American journal of hypertension.
[79] A. Goette,et al. Effect of successful electrical cardioversion on serum aldosterone in patients with persistent atrial fibrillation. , 2001, The American journal of cardiology.
[80] M. Safar,et al. Prevention of aortic and cardiac fibrosis by spironolactone in old normotensive rats. , 2001, Journal of the American College of Cardiology.
[81] G. Vassort,et al. Aldosterone Upregulates Ca2+ Current in Adult Rat Cardiomyocytes , 1999 .
[82] L. Clark,et al. Coronary Artery Aneurysms, Aortic Dissection, and Hypertension Secondary to Primary Aldosteronism: A Rare Triad , 1999, Angiology.
[83] A. Somlyo. Signal transduction: Rhomantic interludes raise blood pressure , 1997, Nature.
[84] K. Weber,et al. Fibrosis of atria and great vessels in response to angiotensin II or aldosterone infusion. , 1997, Cardiovascular research.
[85] M. Safar,et al. Prevention of aortic fibrosis by spironolactone in spontaneously hypertensive rats. , 1997, Arteriosclerosis, thrombosis, and vascular biology.
[86] E. Baulieu,et al. Immunohistochemical and biochemical evidence for a cardiovascular mineralocorticoid receptor. , 1992, Circulation research.
[87] M. Akahoshi,et al. Elevation of plasma renin activity during pregnancy and rupture of a dissecting aortic aneurysm in a patient with primary aldosteronism. , 1983, Japanese heart journal.
[88] G. Curhan,et al. Cardiometabolic outcomes and mortality in medically treated primary aldosteronism: a retrospective cohort study. , 2018, The lancet. Diabetes & endocrinology.
[89] Fiorenzo Gaita,et al. Cardiovascular events and target organ damage in primary aldosteronism compared with essential hypertension: a systematic review and meta-analysis. , 2018, The lancet. Diabetes & endocrinology.
[90] Hong-zhao Li,et al. Aortic cell apoptosis in rat primary aldosteronism model , 2010, Journal of Huazhong University of Science and Technology [Medical Sciences].
[91] K. Lam,et al. The clinicopathologic significance of unilateral adrenal cortical hyperplasia: Report of an unusual case and a review of the literature , 1999, Endocrine pathology.